We are live on ! Find out more
PLSE icon

Pulse Biosciences

51 hedge funds and large institutions have $30.3M invested in Pulse Biosciences in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 6

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

94% more capital invested

Capital invested by funds: $15.6M → $30.3M (+$14.7M)

9% more funds holding

Funds holding: 4751 (+4)

1.05% more ownership

Funds ownership: 10.61%11.66% (+1.1%)

Holders
51
Holders Change
+4
Holders Change %
+8.51%
% of All Funds
1.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
27
Reduced
6
Closed
4
Calls
$394K
Puts
Net Calls
+$394K
Net Calls Change
+$133K
Name Holding Trade Value Shares
Change
Change in
Stake
Citadel Advisors
51
Citadel Advisors
Florida
-$90K -12,555 Closed
Victory Capital Management
52
Victory Capital Management
Texas
-$28K -4,034 Closed
MAM
53
Meeder Asset Management
Ohio
-$1K -186 Closed
PNC Financial Services Group
54
PNC Financial Services Group
Pennsylvania
+$306 +34 New

PLSE Hedge Fund Activity: Q2 2020 in Review

51 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q2 2020, worth a combined $30.3M — up 94% from $15.6M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new PLSE positions and 4 closed out — a net gain of 4 holders — while 27 added to existing stakes and 6 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.46M. The largest seller was Citadel Advisors, exiting entirely with an estimated $90K sold.

  • 51 institutional investors held Pulse Biosciences (PLSE) as of Q2 2020, up from 47 in Q1 2020.
  • Funds reported $30.3M of Pulse Biosciences stock for Q2 2020, up 94% quarter-over-quarter.
  • 8 funds opened new Pulse Biosciences positions in Q2 2020 and 4 closed out, a net change of +4 holders.
  • The largest Pulse Biosciences buyer in Q2 2020 was Vanguard Group, an estimated $1.46M added.
  • The largest Pulse Biosciences seller in Q2 2020 was Citadel Advisors, an estimated $90K sold.

Based on aggregated 13F filings for Q2 2020.